Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions, will be discussing its new comprehensive targeted sequencing service at the International Congress of Human Genetics (ICHG) meeting in Montreal, Canada (11-15 October 2011). The conference, hosted by the American Society of Human Genetics (ASHG), will include an OGT workshop entitled “Adding value through analysis”, which will explain how Targeted Sequencing is being utilised to deliver rapid and cost-effective analysis of human genetic disorders.
Oxford Gene Technology Will Host Workshop at ICHG/ASHG 2011
OGT’s targeted sequencing service is designed to provide meaningful results rather than insurmountable data sets. These are presented via an easy-to-use, interactive analysis report that makes it easy to sort, filter and prioritise the extensively annotated results. This software will be available to view at the show. High-quality data is obtained using a probe design and independently-accredited quality control procedures. OGT’s CEO Dr Mike Evans commented: “OGT is all about producing highly accurate, clear-cut results, and our new sequencing options can be easily combined with other aspects of our Genefficiency™ genomic services offering. In this way, microarray and sequencing data can be fully integrated to provide a highly validated and accurate genomic research solution”.
For more details or to register for the workshop, please visit the company article page.
Company websiteOxford Gene Technology Ltd